Answers are grounded in this paper and cite their sources.
Aging is a multifaceted biological process conceptualized by a gradual decrease in physiological function, which carries enormous socioeconomic challenges globally. This article reviews rapidly evolving boundaries between aging and nanotechnology and nanosystems, examining in detail how molecular mechanisms underlying senescence may be addressed by nanosystems, nanobiotechnology and nanomaterials. We first summarize essential molecular and cell properties underlying aging. We then outline a variety of nanomaterials and nanosystems, such as particles and liposomes, and possible uses of such in prophylactic and therapeutic interventions. The essential portion of this review consolidates experiences from 15 master cases, detailing uses of nanomaterials in preventing or managing disorders associated with age. With reference to therapeutic use, we evaluate broader applicability of nanotechnology in terms of age management, specifically its possible use in diagnostics, in cosmeceuticals, and tissue engineering in terms of regenerative medicine. We then outline current challenges, such as issues in terms of biocompatibility along with regulatory constraints, and consolidate in a forward-looking direction, estimating consequent implications of nanotechnology in terms of prolonging longevity and healthspan in humans. This work shows transformative possibilities of nanotechnology and nanosystemes in terms of radically restructuring clinical approaches as well as aging research. Also this research showed nanotechnology is a coninical point in medical process of aging control in this time and research in this will be increased in future time.
No takes yet. Share an insight, caveat, or question.
Babaali et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: